JG
PDLI

Joel Greenblatt’s PDL BioPharma, Inc. PDLI Stock Holding History

Joel Greenblatt’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-29,531
Closed -$63K – 1188
2016
Q4 		$63K Sell
29,531
-1,236,590
-98% -$3.45M ﹤0.01% 918
2016
Q3 		$4.24M Sell
1,266,121
-1,027,402
-45% -$3.26M 0.06% 384
2016
Q2 		$7.2M Sell
2,293,523
-1,439,156
-39% -$4.8M 0.09% 334
2016
Q1 		$12.4M Sell
3,732,679
-1,016,011
-21% -$3.17M 0.14% 255
2015
Q4 		$16.8M Sell
4,748,690
-297,663
-6% -$1.25M 0.18% 181
2015
Q3 		$25.4M Sell
5,046,353
-2,187,485
-30% -$12.5M 0.25% 144
2015
Q2 		$46.5M Buy
7,233,838
+3,868,364
+115% +$25.9M 0.39% 68
2015
Q1 		$23.7M Buy
3,365,474
+3,182,471
+1,739% +$23M 0.18% 202
2014
Q4 		$1.41M Buy
183,003
+157,006
+604% +$1.24M 0.01% 563
2014
Q3 		$194K Sell
25,997
-763,807
-97% -$7.09M ﹤0.01% 943
2014
Q2 		$7.64M Sell
789,804
-875,739
-53% -$7.81M 0.1% 309
2014
Q1 		$13.8M Sell
1,665,543
-1,678,430
-50% -$14.4M 0.21% 167
2013
Q4 		$28.2M Buy
3,343,973
+453,409
+16% +$3.82M 0.67% 2
2013
Q3 		$23M Buy
2,890,564
+575,183
+25% +$4.62M 0.75% 6
2013
Q2 		$17.9M Buy
+2,315,381
New +$18.1M 0.77% 7

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Joel Greenblatt's PDLI Position: Q1 2017 in Review

Joel Greenblatt sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 29,531 shares — an estimated $63K sold.

Joel Greenblatt first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $46.5M in Q2 2015. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

  • Joel Greenblatt reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • Joel Greenblatt sold 29,531 PDL BioPharma, Inc. shares in Q1 2017, an estimated $63K.
  • Joel Greenblatt first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
  • Joel Greenblatt's PDL BioPharma, Inc. position peaked at $46.5M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Gotham Asset Management's 13F filing for Q1 2017, filed 15 May 2017.